Table 2.
(1) CAPD n = 48 |
(2) CCPD n = 25 |
(3) APD n = 81 |
All n = 154 |
|
---|---|---|---|---|
Dialysis time, h/day(***) | 23.43 ± 2.54(3) | 21.51 ± 4.15(3) | 10.03 ± 0.43(1,2) | 16.30 ± 6.79 |
Cycle, no/day(***) | 3.88 ± 0.44(2,3) | 5.87 ± 0.67(1,3) | 4.82 ± 0.62(1,2) | 4.69 ± 0.88 |
Infused volume, L/day(***) | 8.19 ± 1.58(2,3) | 12.60 ± 1.60(1,3) | 10.20 ± 1.52(1,2) | 9.94 ± 2.15 |
Drained volume, L/day(***) | 9.62 ± 1.74(2,3) | 14.20 ± 1.76(1,3) | 11.39 ± 1.71(1,2) | 11.28 ± 2.30 |
Ultrafiltration, L/day(***) | 1.42 ± 0.50(3) | 1.60 ± 0.69(3) | 1.19 ± 0.44(1,2) | 1.33 ± 0.53 |
Weekly urea KT/V | ||||
Peritoneal urea KT/V(***) | 1.72 ± 0.36(3) | 1.85 ± 0.26(3) | 1.59 ± 0.33(1,2) | 1.68 ± 0.35 |
Renal urea KT/V(***) | 0.34 ± 0.43(2) | 0.04 ± 0.10(1,3) | 0.42 ± 0.54(2) | 0.33 ± 0.48 |
Total urea KT/V(*) | 2.06 ± 0.39(2) | 1.89 ± 0.27(1) | 2.00 ± 0.55 | 2.01 ± 0.47 |
Weekly clearance, L/week | ||||
Peritoneal creatinine clearance(***) | 48.43 ± 13.83(3) | 47.39 ± 10.11(3) | 34.36 ± 10.79(1,2) | 41.11 ± 13.60 |
Renal creatinine clearance(***) | 24.69 ± 37.58(2) | 2.95 ± 7.82(1,3) | 30.03 ± 44.03(2) | 23.80 ± 39.28 |
Total creatinine clearance(***) | 73.12 ± 35.11(2,3) | 50.34 ± 12.22(1) | 64.39 ± 42.06(1) | 64.91 ± 37.12 |
Peritoneal phosphate clearance(***, a) | 41.50 ± 14.50(3) | 36.68 ± 9.56(3) | 25.42 ± 10.18(1,2) | 32.53 ± 13.81 |
Renal phosphate clearance(***, a) | 10.98 ± 14.13(2) | 1.86 ± 7.63(1,3) | 13.80 ± 18.40(2) | 10.90 ± 16.24 |
Total phosphate clearance(***, a) | 52.49 ± 16.42(2,3) | 38.54 ± 12.34(1) | 39.23 ± 19.63(1) | 43.44 ± 18.64 |
Weekly phosphorus removal, g/week | ||||
Peritoneal phosphorus removal(***) | 1.89 ± 0.73(3) | 1.91 ± 0.63(3) | 1.34 ± 0.62(1,2) | 1.61 ± 0.72 |
Renal phosphorus removal(***) | 0.55 ± 0.75(2) | 0.11 ± 0.48(1,3) | 0.67 ± 0.86(2) | 0.54 ± 0.80 |
Total phosphorus removal(***) | 2.44 ± 0.94(2,3) | 2.02 ± 0.85(1) | 2.01 ± 1.00(1) | 2.15 ± 0.97 |
(***) and (*) denote p value < 0.001 and < 0.05 during multi-comparison procedure.
(a)Means significant difference versus creatinine clearance in all investigated therapies and for pooled data.
(1,2,3)Superscripts mean significant difference (p < 0.05) between the current value and the therapies listed in bracket.